Gprc5a-knockout mouse lung epithelial cells predicts ceruloplasmin, lipocalin 2 and periostin as potential biomarkers at early stages of lung tumorigenesis

作者: Beibei Sun , Wenzheng Guo , Song Hu , Feng Yao , Keke Yu

DOI: 10.18632/ONCOTARGET.14589

关键词:

摘要: // Beibei Sun 1, * , Wenzheng Guo 2, 3, Song Hu 1 Feng Yao 4 Keke Yu 5 Jie Xing Ronghua Wang Hongyong 3 Yueling Liao Tong Pengfei Jiang 6 Baohui Han 7 Jiong Deng Translation Medicine Center, Shanghai Chest Hospital, Jiao University, Shanghai, China 2 Key Laboratory of Cell Differentiation and Apoptosis Chinese Minister Education, Department Pathophysiology, University School Medicine, for Tumor Microenvironment Inflammation, Thoracic Surgery, Biobank, East Tongji Pulmonary These authors contributed equally to this work Correspondence to: Han, email: xkyyhan@gmail.com Deng, jiongdeng@shsmu.edu.cn Keywords: lung cancer, biomarker, ceruloplasmin, Gprc5a Received: November 15, 2016      Accepted: December 31, Published: January 10, 2017 ABSTRACT Lung cancer is the leading cause death. As most patients were diagnosed with advanced stage, early detection considered as effective strategy reduce high mortality. Thus, it desirable identify specific biomarkers at stages tumorigenesis. GPRC5A a tumor suppressor gene. deficiency linked development. We hyposthesized that, dysregulated gene expression that results from may provide potential By analysis top 20 upregulated genes in mouse tracheal epithelial cells (MTEC) knockout (KO) vs wild-type (WT), we found lipocalin-2, periostin are not only Gprc5a-ko mice, but also expressed levels tissues mice. This suggests increased these associated Importantly, has been be significantly increased, both mRNA protein levels, NSCLC patients, which correlated repressed GPRC5A. used

参考文章(32)
Steven M Dubinett, David Elashoff, Avrum E Spira, Edward B Garon, Kostyantyn Krysan, Karen L Reckamp, Jay M Lee, Sherven Sharma, Brian K Gardner, Longsheng Hong, Michael C Fishbein, Xiaoyan Cui, Tonya C Walser, Paul C Pagano, Nicole L Rodriguez, Xiaoyan Wang, Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer. American Journal of Translational Research. ,vol. 5, pp. 481- 496 ,(2013)
Ze-Peng Du, Bing-Li Wu, Yang-Min Xie, Ying-Li Zhang, Lian-Di Liao, Fei Zhou, Jian-Jun Xie, Fa-Min Zeng, Xiu-E Xu, Wang-Kai Fang, En-Min Li, Li-Yan Xu, Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop. Biochimica et Biophysica Acta. ,vol. 1853, pp. 2240- 2250 ,(2015) , 10.1016/J.BBAMCR.2015.07.007
Koeffler Hp, Miyoshi I, Park S, Takeuchi S, Koike M, Miller Cw, Mori N, Slater J, Frequent Loss of Heterozygosity in Region of the KIP1 Locus in Non-Small Cell Lung Cancer: Evidence for a New Tumor Suppressor Gene on the Short Arm of Chromosome 12 Cancer Research. ,vol. 56, pp. 738- 740 ,(1996)
Darren R. Flower, The lipocalin protein family: a role in cell regulation FEBS Letters. ,vol. 354, pp. 7- 11 ,(1994) , 10.1016/0014-5793(94)01078-1
LING-ZHI HONG, XIAO-WEI WEI, JIN-FEI CHEN, YI SHI, Overexpression of periostin predicts poor prognosis in non-small cell lung cancer Oncology Letters. ,vol. 6, pp. 1595- 1603 ,(2013) , 10.3892/OL.2013.1590
Binhua P. Zhou, Jiong Deng, Weiya Xia, Jihong Xu, Yan M. Li, Mehmet Gunduz, Mien-Chie Hung, Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition Nature Cell Biology. ,vol. 6, pp. 931- 940 ,(2004) , 10.1038/NCB1173
J. Healy, K. Tipton, Ceruloplasmin and what it might do Journal of Neural Transmission. ,vol. 114, pp. 777- 781 ,(2007) , 10.1007/S00702-007-0687-7
William Pao, Katherine E Hutchinson, Chipping away at the lung cancer genome Nature Medicine. ,vol. 18, pp. 349- 351 ,(2012) , 10.1038/NM.2697
Zhimin Tong, Xuli Wu, Dmitriy Ovcharenko, Jiuxiang Zhu, Ching-Shih Chen, James P. Kehrer, Neutrophil gelatinase-associated lipocalin as a survival factor Biochemical Journal. ,vol. 391, pp. 441- 448 ,(2005) , 10.1042/BJ20051020
Jeffrey J. Rodvold, Navin R. Mahadevan, Maurizio Zanetti, Lipocalin 2 in cancer: when good immunity goes bad. Cancer Letters. ,vol. 316, pp. 132- 138 ,(2012) , 10.1016/J.CANLET.2011.11.002